CD80 and type 1 diabetes mellitus: 10 patients with type 1 diabetes received 10×106 autologous peripheral blood-derived dendritic cells intradermally every 2 weeks for 4 administrations (7 received ex vivo manipulated DC lacking CD80/CD86 while 3 controls received non-manipulated immature DCs).